2008
DOI: 10.1007/s10875-008-9171-x
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmunity in Hyper-IgM Syndrome

Abstract: The mechanisms by which HIGM associates to autoimmunity are not completely elucidated but a defective development of regulatory T cells, the presence of IgM autoantibodies and an impaired peripheral B-cell tolerance checkpoint have been implicated. This article reviews the main subtypes of HIGM syndrome, the clinical autoimmune manifestations found in these patients, and the possible mechanisms that would explain this association.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
56
0
4

Year Published

2010
2010
2019
2019

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 89 publications
(60 citation statements)
references
References 29 publications
0
56
0
4
Order By: Relevance
“…48 Strengthening this possibility, defective CD40-CD40L signaling leads to autoimmunity in both humans and mice. [46][47][48] In this scenario, we propose that recognition of self-peptide-major histocompatibility complexes by high-affinity TCRs expressed on positively selected DP thymocytes may be the mechanism that triggers CD40L expression on nTreg progenitors and leads to feedback maturation of thymic pDCs in vivo, thereby facilitating a functional cross-talk between pDCs and developing thymocytes, resulting in terminal nTreg differentiation. Still, further in vivo studies are required to establish the physiologic relevance of CD40-CD40L in such cross-talk.…”
Section: Discussionmentioning
confidence: 99%
“…48 Strengthening this possibility, defective CD40-CD40L signaling leads to autoimmunity in both humans and mice. [46][47][48] In this scenario, we propose that recognition of self-peptide-major histocompatibility complexes by high-affinity TCRs expressed on positively selected DP thymocytes may be the mechanism that triggers CD40L expression on nTreg progenitors and leads to feedback maturation of thymic pDCs in vivo, thereby facilitating a functional cross-talk between pDCs and developing thymocytes, resulting in terminal nTreg differentiation. Still, further in vivo studies are required to establish the physiologic relevance of CD40-CD40L in such cross-talk.…”
Section: Discussionmentioning
confidence: 99%
“…Consistent with this idea, many patients have poor responses to pneumococcal vaccines following BM transplant, despite having reconstituted normal B cell numbers, and T cell targeting to mitigate graft-versus-host disease further exaggerates this defect (53). In addition, the altered BCR repertoire generated in the absence of CD40 signals may promote autoimmunity because hyper-IgM patients lacking CD40L suffer from various autoimmune symptoms (54). These collective impacts of the CD40 pathway should be taken into account when considering treatments that suppress T cells or CD40 signals because these manipulations are likely to have previously unappreciated effects on the B cell repertoire.…”
Section: /2mentioning
confidence: 97%
“…In addition to the susceptibility to recurrent and opportunistic infections, these patients are also prone to autoimmune complications, especially hematologic abnormalities, autoimmune thyroid disease, nephritis, IBD, and RA. Moreover, organ-specific autoantibodies are commonly found in hyper-IgM patients [88,89,90]. Autoimmune complications mostly occur in patients with activation-induced cytidine deaminase (AID; 25%), NF-κB essential modulator (NEMO; 23%), and CD40 ligand (CD40L; 20%) defects [72].…”
Section: Autoimmunity In Padsmentioning
confidence: 99%